Compounds > 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin
Page last updated: 2024-09-03

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Bleeding

1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Bleeding in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liard, JF1

Other Studies

1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Bleeding

ArticleYear
V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
    The American journal of physiology, 1988, Volume: 255, Issue:6 Pt 2

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Hemodynamics; Hemorrhage; Male; Receptors, Angiotensin; Receptors, Vasopressin; Reference Values; Vascular Resistance

1988